Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 146

1.

Cross-reactivity between human cytomegalovirus peptide 981-1003 and myelin oligodendroglia glycoprotein peptide 35-55 in experimental autoimmune encephalomyelitis in Lewis rats.

Zheng MM, Zhang XH.

Biochem Biophys Res Commun. 2014 Jan 17;443(3):1118-23. doi: 10.1016/j.bbrc.2013.12.122. Epub 2014 Jan 2.

PMID:
24388990
2.
3.

Role of pathogenic T cells and autoantibodies in relapse and progression of myelin oligodendrocyte glycoprotein-induced autoimmune encephalomyelitis in LEW.1AV1 rats.

Matsumoto Y, Park IK, Hiraki K, Ohtani S, Kohyama K.

Immunology. 2009 Sep;128(1 Suppl):e250-61. doi: 10.1111/j.1365-2567.2008.02955.x. Epub 2008 Oct 29.

6.

Antibody response in Lewis rats injected with myelin oligodendrocyte glycoprotein derived peptides.

Ichikawa M, Johns TG, Adelmann M, Bernard CC.

Int Immunol. 1996 Nov;8(11):1667-74.

PMID:
8943561
7.

The N-terminal domain of the myelin oligodendrocyte glycoprotein (MOG) induces acute demyelinating experimental autoimmune encephalomyelitis in the Lewis rat.

Adelmann M, Wood J, Benzel I, Fiori P, Lassmann H, Matthieu JM, Gardinier MV, Dornmair K, Linington C.

J Neuroimmunol. 1995 Dec;63(1):17-27.

PMID:
8557821
8.

T cells specific for the myelin oligodendrocyte glycoprotein mediate an unusual autoimmune inflammatory response in the central nervous system.

Linington C, Berger T, Perry L, Weerth S, Hinze-Selch D, Zhang Y, Lu HC, Lassmann H, Wekerle H.

Eur J Immunol. 1993 Jun;23(6):1364-72.

PMID:
7684687
9.

Molecular and genetic requirements for preferential recruitment of TCRBV8S2+ T cells in Lewis rat experimental autoimmune encephalomyelitis.

Weissert R, Svenningsson A, Lobell A, de Graaf KL, Andersson R, Olsson T.

J Immunol. 1998 Jan 15;160(2):681-90.

10.

T and B cell responses to myelin basic protein and encephalitogenic epitopes.

Gould KE, Swanborg RH.

J Neuroimmunol. 1993 Jul;46(1-2):193-8.

PMID:
7689588
11.

Clinicopathological study of a myelin oligodendrocyte glycoprotein-induced demyelinating disease in LEW.1AV1 rats.

Sakuma H, Kohyama K, Park IK, Miyakoshi A, Tanuma N, Matsumoto Y.

Brain. 2004 Oct;127(Pt 10):2201-13. Epub 2004 Jul 28.

PMID:
15282218
13.

Suppressive DNA vaccination in myelin oligodendrocyte glycoprotein peptide-induced experimental autoimmune encephalomyelitis involves a T1-biased immune response.

Lobell A, Weissert R, Eltayeb S, de Graaf KL, Wefer J, Storch MK, Lassmann H, Wigzell H, Olsson T.

J Immunol. 2003 Feb 15;170(4):1806-13.

15.
16.

Molecular mimicry between a viral peptide and a myelin oligodendrocyte glycoprotein peptide induces autoimmune demyelinating disease in mice.

Mokhtarian F, Zhang Z, Shi Y, Gonzales E, Sobel RA.

J Neuroimmunol. 1999 Mar 1;95(1-2):43-54.

PMID:
10229114
17.

Superantigen overcomes resistance of IL-6-deficient mice towards MOG-induced EAE by a TNFR1 controlled pathway.

Eugster HP, Frei K, Winkler F, Koedel U, Pfister W, Lassmann H, Fontana A.

Eur J Immunol. 2001 Aug;31(8):2302-12.

18.
19.
20.

Chronological changes of CD4(+) and CD8(+) T cell subsets in the experimental autoimmune encephalomyelitis, a mouse model of multiple sclerosis.

Sonobe Y, Jin S, Wang J, Kawanokuchi J, Takeuchi H, Mizuno T, Suzumura A.

Tohoku J Exp Med. 2007 Dec;213(4):329-39.

Supplemental Content

Support Center